Reboxetine

Records for this ingredient, by country (identity only).

ATC N06AX18 · 4 markets · 22 records

Reboxetine 4 markets · 22 records Forms

Filters

MarketGB 11 CN 8 ES 2 AU 1

Strength

GB 11 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

4 mgtabletEdronax 4mg tablets+1Manufacturer: Imported also in CN·ES·AU

CN 8 records · 2 shown of 2 Source 国家医保局医保药品分类与代码数据库 · Data as of 2025-04-04

4 mgtablet佐乐辛瑞波西汀+2叶洛抒、Manufacturer: 北京红林制药有限公司 also in GB·ES·AU
4 mgcapsule叶洛抒瑞波西汀

ES 2 records · 1 shown of 1 Source CIMA (AEMPS) · Data as of live

4 mgtabletIRENOR+1NOREBOX also in GB·CN·AU

AU 1 records · 1 shown of 1 Source PBS Schedule API v3 (Department of · Data as of 2026-10-01

4 mgtabletEdronax 4mg tablets also in GB·CN·ES

Side-by-side table

Strength / form / release	GB	AU	CN	ES
4 mg tablet	Manufacturer: Imported Edronax 4mg tablets	Edronax 4mg tablets	Manufacturer: 北京红林制药有限公司 ×3 佐乐辛瑞波西汀叶洛抒瑞波西汀	IRENOR NOREBOX
4 mg capsule	not recorded	not recorded	叶洛抒瑞波西汀	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

Also called: 甲磺酸瑞波西汀 nickname

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.